DrugPatentWatch Database Preview
SYNJARDY Drug Profile
When do Synjardy patents expire, and when can generic versions of Synjardy launch?
This drug has one hundred and eight patent family members in thirty-four countries.
The generic ingredient in SYNJARDY is empagliflozin; metformin hydrochloride. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the empagliflozin; metformin hydrochloride profile page.
Summary for SYNJARDY
International Patents: | 108 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 2 |
Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
Drug Prices: | see details |
DailyMed Link: | SYNJARDY at DailyMed |

Pharmacology for SYNJARDY
Ingredient-type | Biguanides |
Drug Class | Sodium-Glucose Cotransporter 2 Inhibitor Biguanide |
Mechanism of Action | Sodium-Glucose Transporter 2 Inhibitors |
US Patents and Regulatory Information for SYNJARDY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Boehringer Ingelheim | SYNJARDY XR | empagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208658-004 | Dec 9, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
Boehringer Ingelheim | SYNJARDY XR | empagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208658-002 | Dec 9, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
Boehringer Ingelheim | SYNJARDY XR | empagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208658-001 | Dec 9, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Boehringer Ingelheim | SYNJARDY XR | empagliflozin; metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 208658-002 | Dec 9, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for SYNJARDY
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
Patent No. | Title | Estimated Patent Expiration |
---|---|---|
7,687,469 | Glucopyranosyl-substituted benzene derivatives, medicaments containing such compounds, their use and process for their manufacture | ➤ Try a Free Trial |
Patent No. | Title | Estimated Patent Expiration |
International Patents for SYNJARDY
Country | Document Number | Estimated Expiration |
---|---|---|
Japan | 2007246544 | ➤ Try a Free Trial |
Croatia | P20100033 | ➤ Try a Free Trial |
South Africa | 200605511 | ➤ Try a Free Trial |
Taiwan | 200716586 | ➤ Try a Free Trial |
Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for SYNJARDY
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|
1730131/02 | Switzerland | ➤ Try a Free Trial | PRODUCT NAME: EMPAGLIFLOZIN UND METFORMINHYDROCHLORID; REGISTRATION NO/DATE: SWISSMEDIC 65570 12.11.2015 |
C0074 | France | ➤ Try a Free Trial | PRODUCT NAME: EMPAGLIFLOZINE ET SES SELS, EN PARTICULIER L'EMPAGLIFLOZINE; REGISTRATION NO/DATE: EU/1/14/930 20140522 |
1730131/01 | Switzerland | ➤ Try a Free Trial | PRODUCT NAME: EMPAGLIFLOZIN; REGISTRATION NO/DATE: SWISSMEDIC 63227 12.11.2014 |
00696 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: EMPAGLIFLOZINE EN ZOUTEN DAARVAN, IN HET BIJZONDER EMPAGLIFLOZINE; REGISTRATION NO/DATE: EU/1/14/930/001-009 20140522 |
Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |